Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Medincell Promotes Grace Kim Chief Strategy Officer U.S. Finance | Contract Pharma
Breaking News, Promotions & Moves

Medincell Promotes Grace Kim Chief Strategy Officer U.S. Finance

Over the past 2 years, Kim has built a strong foundation that will be built upon to advance into the next stage of U.S. capital growth.

Medincell, a clinical-stage pharmaceutical company in long-acting injectable therapies, today announced the expanded role of Dr Grace Kim, Chief Strategy Officer, U.S. Finance.

Over the past two years, Kim has played has initial and decisive role in shaping the company’s U.S. capital growth strategy and advancing cross-border initiatives.

As Medincell enters a pivotal growth phase, Kim will build on this foundation to lead and execute the next stages of the company’s U.S. capital growth strategy, driving long-term value for patients, partners, and investors.

Kim serves as Medincell’s Chief Strategy Officer, U.S. Finance, acting as an execution partner for the company’s U.S. capital strategy and global expansion.

Kim has two decades of experience in Capital Markets, Corporate Strategy, and Investment Banking. Kim previously served as Chief Strategy Officer of Molecular Templates and CEO of SNO Bio. She also leads a longstanding NY biotech advisory. 

With a $10 billion track record, Grace has driven value for over 160 companies, including BeiGene/BeOne, Biomarin, Cullinan Therapeutics, Zai Lab, Aimmune/Nestle, Immunity Bio, and Umoja Biopharma. 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters